Finance

Lists
Why is JSPR up 3,10%?
Dive Deeper
JSPR:NASDAQ
Jasper Therapeutics Inc
0,60 $
+3,10%
(+0,018) 1D
0,67 $
+12,07% (+0,072)
Pre-market
Closed: 1 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for JSPR...
Open
0,59 $
High
0,64 $
Low
0,58 $
Mkt. cap
19,90 մլն
Avg. vol.
442,42 հզր
Volume
1,39 հզր
52-wk high
2,69 $
52-wk low
0,32 $
EPS
-1,58 $
Beta
3,04
Shares outstanding
33,28 մլն
No. of employees
22
Open
0,59 $
High
0,64 $
Low
0,58 $
Mkt. cap
19,90 մլն
Avg. vol.
442,42 հզր
Volume
1,39 հզր
52-wk high
2,69 $
52-wk low
0,32 $
EPS
-1,58 $
Beta
3,04
Shares outstanding
33,28 մլն
No. of employees
22
News stories
From web sources and news partners
About Jasper Therapeutics Inc
CEO-
Employees22
Founded2018
HeadquartersՌեդվուդ Սիթի, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Analyst ratings
Based on 2 analysts giving stock ratings to JSPR in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for JSPR in the last 3 months.
Highest
Current 0,60 $
20,00 $ (+3 244,48%)
Average
11,00 $ (+1 739,46%)
Lowest
2,00 $ (+234,45%)
Analyst
Recommendation
Action
Price target
Projected
Date
Emily Bodnar
H.C. Wainwright
Buy
Maintained
20,00 $
+3 244,5%
09/21/2026
Biren Amin
Piper Sandler
Buy
Initiated
2,00 $
+234,4%
08/12/2026
Matt Phipps
William Blair
Hold
Maintained
-
-
06/01/2026
Leonid Timashev
RBC Capital
Hold
Maintained
3,00 $
+401,7%
05/14/2026
Yaron Werber
TD Cowen
Hold
Downgraded
-
-
05/15/2026
David Dai
UBS
Hold
Maintained
1,50 $
+150,8%
04/02/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
7,00 $
+1 070,6%
04/01/2026
Michael King
Rodman & Renshaw
Buy
Initiated
17,00 $
+2 742,8%
01/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
13,10 մլն
10,85 մլն
5,81 մլն
5,14 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,26 մլն
4,49 մլն
5,14 մլն
4,07 մլն
Operating expense
17,36 մլն
15,35 մլն
10,95 մլն
9,21 մլն
Total operating expenses
17,36 մլն
15,35 մլն
10,95 մլն
9,21 մլն
Operating income
-17,36 մլն
-15,35 մլն
-10,95 մլն
-9,21 մլն
Other non operating income
88,00 հզր
6,40 մլն
9,61 մլն
6,36 մլն
EBT including unusual items
-18,74 մլն
-9,10 մլն
-1,17 մլն
-2,76 մլն
EBT excluding unusual items
-16,93 մլն
-8,61 մլն
-1,17 մլն
-2,76 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-18,74 մլն
-9,10 մլն
-1,17 մլն
-2,76 մլն
Net profit margin
-
-
-
-
Earnings per share
-1,25
-0,54
-0,38
-0,23
Interest and investment income
342,00 հզր
338,00 հզր
164,00 հզր
82,00 հզր
Interest expense
-
-
-
-
Net interest expenses
342,00 հզր
338,00 հզր
164,00 հզր
82,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-17,13 մլն
-15,06 մլն
-10,93 մլն
-9,19 մլն
Gain or loss from assets sale
-2,00 հզր
-
-
-80,00 հզր
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps